In addition, PD-1 tumor expression was observed with 18F-BMS-986192 in patients with low PD-L1 expression, as determined by immunohistochemistry, most likely due to tumor PD-L1 expression heterogeneity. This evidence concerns the gene CD274 and neoplasm.